PRODUCTS
SERVICES
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
2.37
1 yrs 2 m
1%
303.62 Crs
1% on or before 1M, Nil after 1M
Large Growth
8.22
SIP 100 & Lumpsum 500
NA
Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal
Investors understand that their principal will be at very high risk